Anmol Baranwal
17PUBLICATIONS
52CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (17)
Sort by Publication Date:
|May 07, 2025
Validation of the 5th edition of the World Health Organization and International Consensus Classification guidelines for TP53-mutated myeloid neoplasm in an independent international cohort.Mithun Vinod Shah, Kevin Hung, Anmol Baranwal
|Mar 14, 2025
Factors associated with survival after allogeneic transplantation for myeloid neoplasms harboring TP53 mutations.Anmol Baranwal, Kimberly J Langer, Vedavyas Gannamani
|Mar 14, 2025
Evidence-based risk stratification of myeloid neoplasms harboring TP53 mutations.Mithun Vinod Shah, Kevin Hung, Anmol Baranwal
|Apr 02, 2024
The impact of cytotoxic therapy on the risk of progression and death in clonal cytopenia(s) of undetermined significance.Marissa Li, Anmol Baranwal, Mark Gurney
|May 05, 2023
The clinical and molecular spectrum of ETV6 mutated myeloid neoplasms.Mark Gurney, Ismahene Chekkaf, Anmol Baranwal
|Apr 11, 2023
TP53 mutation variant allele frequency of ≥10% is associated with poor prognosis in therapy-related myeloid neoplasms.Mithun Vinod Shah, Elizabeth Ngoc Hoa Tran, Syed Shah
Pageof 3
Frequent Collaborators
15 joint publications
Mithun Vinod Shah
8 joint publications
Mark R Litzow
7 joint publications
Mrinal M Patnaik
7 joint publications
William J Hogan
6 joint publications
Abhishek Mangoankar
6 joint publications
Naseema Gangat
6 joint publications
Aref Al-Kali
5 joint publications
Chung Hoow Kok
5 joint publications
Rong He
5 joint publications
Talha Badar
